Baxter Infusion Pump Recall

By Austin Kirk
Posted July 24, 2007

ADD YOUR COMMENTS

On July 20, 2007, the FDA announced a Baxter infusion pump recall as a result of software irregularities in upgraded Colleague Triple Channel Volumetric Infusion Pumps.  The product defect could cause life-sustaining therapy to stop unexpectedly, which may result in serious injury or death.  The recall lawyers at Saiontz & Kirk, P.A. are reviewing potential Baxter infusion pump lawsuits for those who have been injured.

>>INFORMATION: Infusion Pump Recall Lawsuits

This is not the first problem associated with Baxter infusion pumps.  Baxter Healthcare Corp. previously issued three different recalls of their Colleague Volumetric Infusion Pumps in 2005.  This new recall involves one of the upgraded replacements for the Triple Channel Infusion Pump. 

Infusion pumps are used to administer controlled amounts of fluid or medication through IV (intravenous), intra-arterial,  epidural or other direct lines into the blood stream.  The defect in the upgraded infusion pump could cause the device to display an error code and stop the therapy during user programming while all three channels are infusing fluids at the same time.

There have been reports of at least 16 serious injuries  linked to the defective infusion pumps.  The company has distributed approximately 4,512 of the pumps to 420 hospitals and medical facilities in the United States and 7 outside the U.S.  They were placed in service between May 14, 2007 and June 18, 2007.  All facilities and distributors have been notified to remove the triple channel pumps from service immediately.

INFUSION PUMP LAWSUITS

If problems are experienced while fluids or medication were administered by an infusion pump, compensation may be available. Contact our infusion pump recall lawyers to review your claim and obtain a free consultation.